YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Gilead Sciences agreed to buy Kite Pharma for $11 billion, people familiar with the matter told Dow Jones Newswires.
The all-cash deal would give Gilead access to Kite Pharma's new technology designed to harness the body's immune system to fight cancer.
Foster City, California-based Gilead's portfolio includes infectious-disease treatments.
Read more from Dow Jones Newswires.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach